Jefferies Initiates Coverage On Braveheart Bio with Buy Rating, Announces Price Target of $48

Benzinga · 3d ago
Jefferies initiates coverage on Braveheart Bio (NASDAQ:BRVE) with a Buy rating and announces Price Target of $48.